Moderna, Inc. (0QF.F) XETRA

22.92

-0.89(-3.74%)

Updated at July 01 03:34PM

Currency In EUR

Moderna, Inc.

Address

200 Technology Square

Cambridge, MA 02139

United States of America

Phone

617 714 6500

Sector

Healthcare

Industry

Biotechnology

Employees

5800

First IPO Date

December 12, 2018

Key Executives

NameTitlePayYear Born
Mr. Stephane BancelChief Executive Officer & Director4.08M1973
Mr. James M. MockChief Financial Officer1.3M1977
Ms. Shannon Thyme Klinger J.D.Chief Legal Officer & Corporate Secretary1.44M1971
Dr. Stephen Hoge M.D.President2.28M1976
Dr. Melanie Ivarsson M.B.A., Ph.D.Chief Development Officer0N/A
Mr. Dave JohnsonChief Data & AI Officer0N/A
Dr. Jerh Collins Ph.D.Chief Technical Operations & Quality Officer01967
Dr. Charbel Haber M.P.H., Ph.D.Senior Vice President & Head of Global Regulatory Science0N/A
Ms. Lavina Talukdar CFASenior Vice President & Head of Investor Relations01974
Ms. Tracey FranklinChief People & Digital Technology Officer01980

Description

Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, respiratory syncytial virus, Endemic HCoV, and hMPV+PIV3 vaccines; latent vaccines comprise cytomegalovirus, epstein-barr virus, human immunodeficiency virus, herpes simplex virus, and varicella-zoster virus vaccines; and public health vaccines consists of Zika and Nipah vaccines. The company also offers systemic secreted and cell surface therapeutics; cancer vaccines, such as personalized cancer, KRAS, and checkpoint vaccines; intratumoral immuno-oncology products; localized regenerative, systemic intracellular, and inhaled pulmonary therapeutics. It has strategic alliances with AstraZeneca PLC; Merck & Co., Inc.; Vertex Pharmaceuticals Incorporated; Vertex Pharmaceuticals (Europe) Limited; Carisma Therapeutics, Inc.; Metagenomi, Inc.; the Defense Advanced Research Projects Agency; Biomedical Advanced Research and Development Authority; Institute for Life Changing Medicines; and The Bill & Melinda Gates Foundation, as well as a collaboration and license agreement with Chiesi Farmaceutici S.P.A. The company was formerly known as Moderna Therapeutics, Inc. and changed its name to Moderna, Inc. in August 2018. Moderna, Inc. was founded in 2010 and is headquartered in Cambridge, Massachusetts.